News


All News

New York - While acitretin remains a common oral treatment for psoriasis, oral tazarotene (Allergan), fumaric acid esters (FAEs), and oral pimecrolimus can cut side effects ranging from alopecia to liver and kidney damage, according to a recent study.

Research shows that less than half of patients with severe psoriasis in the United States receive aggressive treatment - systemic drugs, biologic drugs or phototherapy - for their disease. The total number of severely psoriatic patients has been estimated at 120,000 to 450,000 or more.

New York - Results of a retrospective review reinforce the long-term safety and tolerability of repeated treatments with botulinum toxin type A (Botox Cosmetic?, Allergan) for cosmetic reasons, said Alastair Carruthers, M.D., at the American Academy of Dermatology's Academy '04 here recently.

New Orleans - BAY 43-9006, a novel signal transduction inhibitor, has very modest activity as a single agent in melanoma; however, it has promising activity in combination with chemotherapy, investigators said at the annual meeting of the American Society of Clinical Oncology (ASCO).

Controversial as they are, the new regulations have focused attention on the complex payroll withholding system that every dermatology practice must deal with.

You're fired

Firing a patient or terminating the physician-patient relationship (PPR)... requires following a certain protocol in order to be accomplished successfully, without risk of litigation from the patient and/or the family.

International report - Some soldiers serving in Iraq say military policies that restrict the wearing of hats during physical training are leaving them unprotected from potentially deadly sun exposure.

New York - Melanoma-derived peptide vaccines are currently an exciting area of melanoma immuno-therapy research, according to Douglas J. Schwartzentruber, M.D., medical director and director of the Center for Cancer Care at Goshen Health System, Goshen, Ind., speaking at the Society of Surgical Oncology annual meeting.

Eilat, Israel - For the last 50 years, hydroquinone has been the reference of treatment in hyperpigmentations, and more recently, combination formulas, peelings and adjuvant therapies including sunscreens containing the drug, show promise. However, topical agents have yet to prove a constant and uncontested efficiency, said Daphne Thioly-Bensoussan M.D., during the 28th Annual Meeting of the Israeli Conference of Dermatology and Venerology.

Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.

New York - You wouldn't perform a medical procedure without preparation. Nor should you participate in a print or broadcast-media interview without making sure you're ready.

Finally - and perhaps most crucial, says Dr. Goode - there is this question: Is there anything like the new device available? Because if there isn't, the new device could draw the attention of manufacturing or distributing companies.

Acne

Alan Shalita, M.D., Ph.D., a leader in acne research, has studied the condition for more than 30 years.

Pigmentary Disorders

Albert Kligman, M.D., Ph.D., explores pigmentary disorders and develops enduring treatments

Rosacea

Albert Kligman, M.D., Ph.D., is a pioneer who continues to break new ground in dermatology.

Stanford, Calif. - To be truly successful in a cosmetic surgery dermatology practice, it is important to think beyond garnering surgical ability. While such ability is essential, it is not the only aspect of a practice that surgeons should think about, says David R. Harris, M.D., a clinical professor at Stanford University School of Medicine.